QTLs in Region (GRCr8)
| 631688 | Hcas2 | Hepatocarcinoma susceptibility QTL 2 | 3 | 0.0001 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 1 | 7746118 | 52746118 | Rat |
| 4889451 | Eae29 | Experimental allergic encephalomyelitis QTL 29 | 5.51 | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis severity score (CMO:0001419) | 1 | 7746121 | 52746121 | Rat |
| 1357397 | Bw41 | Body weight QTL 41 | 4.19 | 0.0001 | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 29409279 | 74409279 | Rat |
| 70179 | Xhs2 | X-ray hypersensitivity QTL 2 | 3.2 | | intestine integrity trait (VT:0010554) | post-insult time to onset of moribundity (CMO:0001896) | 1 | 1 | 43965634 | Rat |
| 1358359 | Sradr1 | Stress Responsive Adrenal Weight QTL 1 | 4.74 | | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 1 | 39728272 | 132889942 | Rat |
| 1558642 | Prcr2 | Prostate cancer resistance QTL 2 | 4.3 | | prostate integrity trait (VT:0010571) | area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) | 1 | 10379492 | 55379492 | Rat |
| 1354643 | Foco2 | Food consumption QTL 2 | 7.17 | 0.0001 | eating behavior trait (VT:0001431) | food intake rate (CMO:0000427) | 1 | 42122968 | 87122968 | Rat |
| 7421626 | Bp360 | Blood pressure QTL 360 | | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 1 | 6941022 | 51941022 | Rat |
| 1357401 | Bw43 | Body weight QTL 43 | 3.75 | | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 6909353 | 51909353 | Rat |
| 631494 | Bp95 | Blood pressure QTL 95 | 40 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 17315378 | 51816258 | Rat |
| 5684998 | Bss101 | Bone structure and strength QTL 101 | 3.6 | | tibia strength trait (VT:1000284) | tibia ultimate force (CMO:0001734) | 1 | 6909353 | 51909353 | Rat |
| 70225 | Bp58 | Blood pressure QTL 58 | 3.3 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 34184556 | 172281316 | Rat |
| 5684999 | Bss102 | Bone structure and strength QTL 102 | 5.5 | 7e-07 | tibia strength trait (VT:1000284) | tibia stiffness (CMO:0001735) | 1 | 6909353 | 51909353 | Rat |
| 1354599 | Bw29 | Body weight QTL 29 | 3.46 | 0.001 | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 42122968 | 87122968 | Rat |
| 10059597 | Bp377 | Blood pressure QTL 377 | 3.42 | 0.025 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 34565911 | 208798288 | Rat |
| 2302038 | Pia31 | Pristane induced arthritis QTL 31 | 5.5 | 0.001 | blood autoantibody amount (VT:0003725) | serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) | 1 | 12820494 | 57820494 | Rat |
| 634353 | Rends2 | Renal damage susceptibility QTL 2 | | 0.05 | kidney blood vessel morphology trait (VT:0000530) | organ lesion measurement (CMO:0000677) | 1 | 20656420 | 65656420 | Rat |
| 1578756 | Iddm22 | Insulin dependent diabetes mellitus QTL 22 | 2.7 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 20508326 | 65508326 | Rat |
| 631508 | Sald1 | Serum aldosterone level QTL 1 | 3.7 | | blood aldosterone amount (VT:0005346) | serum aldosterone level (CMO:0000487) | 1 | 11684464 | 56684464 | Rat |
| 1331785 | Rf27 | Renal function QTL 27 | 4.643 | | urine sodium amount (VT:0006274) | urine sodium level (CMO:0000129) | 1 | 30708375 | 87558729 | Rat |
| 1300172 | Bp172 | Blood pressure QTL 172 | 3.56 | | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 1 | 34565726 | 79565726 | Rat |
